Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Wallenius Wilhelmsen WAWIO Mar 3, 2021 24.60 0.00   
 Wallenstam B WALLB Mar 3, 2021 118.70 -0.25   
 Waystream Holding WAYS Mar 3, 2021 14.40 -0.69   
 Webstep WSTEPO Mar 3, 2021 22.00 0.00   
 WeSC WESC Mar 3, 2021 1.99 +0.91   
 Westpay WPAY Mar 3, 2021 2.46 +0.41   
 Wihlborgs Fastigheter WIHL Mar 3, 2021 165.10 -0.60   
 Wilh. Wilhelmsen Holding ser. A WWIO Mar 3, 2021 168.00 0.00   
 WilLak WIL Mar 3, 2021 0.18 -1.10   
 Wise Group WISE Mar 3, 2021 35.70 -0.28   
 WntResearch WNT Mar 3, 2021 1.20 +5.26   
 Wonderful Times Group WTG Mar 3, 2021 16.30 -0.61   
 Wästbygg WBGRB Mar 3, 2021 100.00 -1.48   
 Xact Bear XACTBEAR Mar 3, 2021 28.81 -0.28   
 Xact Bear 2 XACTBEAR2 Mar 3, 2021 18.06 -0.45   
 Xact Bull XACTBULL Mar 3, 2021 562.00 +0.27   
 Xact Bull 2 XACTBULL2 Mar 3, 2021 1 166.00 +0.47   
 XACT Högutdelande XACTHDIV Mar 3, 2021 125.18 +0.21   
 Xact OMXS30 XACTOMXS30 Mar 3, 2021 263.55 +0.04   
 XANO Industri B XANOB Mar 3, 2021 154.00 -1.91   
 Xavitech B XAVIB Mar 3, 2021 1.26 +0.80   
 Xbrane Biopharma XBRANE Mar 3, 2021 104.50 +1.95   
 Xintela XINT Mar 3, 2021 2.83 -4.39   
 XMReality XMR Mar 3, 2021 7.78 -2.02   
 Xspray Pharma XSPRAY Mar 3, 2021 118.50 -0.42   
 Xvivo Perfusion XVIVO Mar 3, 2021 323.00 -1.37   
 XXL XXLO Mar 3, 2021 18.90 0.00   
 Yara International YARO Mar 3, 2021 422.40 0.00   
 Zalaris ZALO Mar 3, 2021 54.20 0.00   
 Zaplox ZAPLOX Mar 3, 2021 0.39 -1.02   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK